Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Bibliographic Details
Main Authors:	V. La, R. Fujikawa, D. M. Janzen, M. Nunez, L. Bainvoll, L. Hwang, K. Faull, G. Lawson, S. Memarzadeh
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-08-01
Series:	npj Precision Oncology
Online Access:	https://doi.org/10.1038/s41698-021-00217-9

Similar Items

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
by: V. La, et al.
Published: (2017-04-01)

Cytoplasmic and Nuclear Functions of cIAP1
by: Aymeric Zadoroznyj, et al.
Published: (2022-02-01)

IKK∊-Mediated Tumorigenesis Requires K63-Linked Polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 Ubiquitin Ligase Complex
by: Alicia Y. Zhou, et al.
Published: (2013-03-01)

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
by: Edward Z. Song, et al.
Published: (2022-12-01)

TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
by: Xu Yang, et al.
Published: (2022-12-01)

Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis
by: Debolina D. Biswas, et al.
Published: (2022-06-01)

Loss of cIAP1 in Endothelial Cells Limits Metastatic Extravasation through Tumor-Derived Lymphotoxin Alpha
by: Lazaros Vasilikos, et al.
Published: (2021-02-01)

A20 Promotes Ripoptosome Formation and TNF-Induced Apoptosis via cIAPs Regulation and NIK Stabilization in Keratinocytes
by: Maria Feoktistova, et al.
Published: (2020-02-01)

Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies
by: Lam Stephen, et al.
Published: (2005-12-01)

E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
by: Nicholson, J, et al.
Published: (2017)

cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs
by: Kawalkowska, JZ, et al.
Published: (2019)

Anastasis enhances metastasis and chemoresistance of colorectal cancer cells through upregulating cIAP2/NFκB signaling
by: Ru Wang, et al.
Published: (2023-06-01)

Role of the TWEAK-Fn14-cIAP1-NF-kB signaling axis in the regulation of myogenesis and muscle homeostasis
by: Emeka K Enwere, et al.
Published: (2014-02-01)

TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs
by: Monika Vashisht, et al.
Published: (2023-09-01)

The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
by: Julia Fleischmann, et al.
Published: (2023-06-01)

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
by: Weiyan Zhang, et al.
Published: (2024-03-01)

Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo
by: Emma Morrish, et al.
Published: (2020-08-01)

Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells
by: Ming-Hsien Chien, et al.
Published: (2020-03-01)

PDP-6 IAP
by: White, John L.
Published: (2004)

An Updated Review of Smac Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment
by: Yung-Chieh Chang, et al.
Published: (2020-12-01)

Cognitive impairment associated with psychosis (CIAPS): Validity of clinical criteria to detect cognitive impairment
by: A. Sánchez-Torres, et al.
Published: (2021-04-01)

Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian Cancer
by: Hanieh Meteran, et al.
Published: (2024-02-01)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
by: Susann Badmann, et al.
Published: (2022-02-01)

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.
by: Zweifel, M, et al.
Published: (2011)

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial
by: Fatéméh Dubois, et al.
Published: (2019-11-01)

Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin
by: Rachel Coyle, et al.
Published: (2022-01-01)

Chemical degradation of platinum oncolytics in urine and speciation of the inorganic contaminants cisplatin and carboplatin relevant in waste water
by: Karel Folens, et al.
Published: (2024-03-01)

17.922 Dr. Martin Luther King, Jr. IAP Design Seminar, January IAP 2013
by: Weiner, Tobie
Published: (2023)

Phase IB dose-escalation and expansion study of AKT kinase inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer
by: Blagden, S, et al.
Published: (2018)

Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)
by: Laurence Dubrez, et al.
Published: (2013-03-01)

Retraction Note: The role of apatinib combined with paclitaxel (aluminum binding type) in platinum-resistant ovarian cancer
by: Hong Zhao, et al.
Published: (2021-02-01)

Męczeństwo Piłata (Homilia de morte Pilati sive Martyrium Pilati, CIApNT 75)
by: Rafał Zarzeczny
Published: (2002-03-01)

8.20 Introduction to Special Relativity, January (IAP) 2003
by: Jaffe, Robert L.
Published: (2003)

XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant
by: Christophe Van Berckelaer, et al.
Published: (2024-05-01)

Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers
by: Adam Neal, et al.
Published: (2021-11-01)

12.141 Electron Microprobe Analysis, January (IAP) 2003
by: Chatterjee, Nilanjan, et al.
Published: (2003)

Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).
by: Larissa Hube, et al.
Published: (2017-01-01)

IIAEK Targets Intestinal Alkaline Phosphatase (IAP) to Improve Cholesterol Metabolism with a Specific Activation of IAP and Downregulation of ABCA1
by: Asahi Takeuchi, et al.
Published: (2020-09-01)

Targeting c-IAP1, c-IAP2, and Bcl-2 Eliminates Senescent Glioblastoma Cells Following Temozolomide Treatment
by: Christian Schwarzenbach, et al.
Published: (2021-07-01)

Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results
by: Zweifel, M, et al.
Published: (2009)